RecruitingPhase 1NCT06902987

Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

Studying Anal fistula

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Intervention
Upadacitinib(drug)
Enrollment
27 enrolled
Eligibility
18-70 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06902987 on ClinicalTrials.gov

Other trials for Anal fistula

Additional recruiting or active studies for the same condition.

See all trials for Anal fistula

← Back to all trials